Merck Canada Inc. Supports New Network to Address Diabetes Complications

MONTREAL, March 31, 2016 /CNW Telbec/ - Today, Health Minister Jane Philpott announced funding from the Canadian Institutes for Health Research (CIHR) for five 'Strategy for Patient-Oriented Research' (SPOR) Networks in Chronic Disease, including the SPOR Network in Diabetes and Related Complications. Merck Canada Inc. is a proud sponsor of the network, which aims to transform the health outcomes of individuals with diabetes and its related complications. (From left to right) Dr. Jean-Pierre Després of the Faculty of Medecine at the Université Laval; the Honourable Jane Philpott, Minister of Health; Dr. Gary Lewis, Director of the Banting and Best Diabetes Centre at the University of Toronto and Senior Scientist with the University Health Network; Ms. Jennifer Chan, Vice-President, Policy and External Affairs at Merck Canada Inc.; Dr. Catharine Whiteside, Emerita Professor at the Department of Medicine of the University of Toronto and Mr. Jean-François Richard, Associate Director of Scientific Affairs at Merck Canada Inc.

SOURCE Merck Canada Inc.

Image with caption: "Merck Canada Inc. Supports New Network to Address Diabetes Complications - Today, Health Minister Jane Philpott announced funding from the Canadian Institutes for Health Research (CIHR) for five ‘Strategy for Patient-Oriented Research’ (SPOR) Networks in Chronic Disease, including the SPOR Network in Diabetes and Related Complications. Merck Canada Inc. is a proud sponsor of the network, which aims to transform the health outcomes of individuals with diabetes and its related complications. (From left to right) Dr. Jean-Pierre Després of the Faculty of Medecine at the Université Laval; the Honourable Jane Philpott, Minister of Health; Dr. Gary Lewis, Director of the Banting and Best Diabetes Centre at the University of Toronto and Senior Scientist with the University Health Network; Ms. Jennifer Chan, Vice-President, Policy and External Affairs at Merck Canada Inc.; Dr. Catharine Whiteside, Emerita Professor at the Department of Medicine of the University of Toronto and Mr. Jean-François Richard, Associate Director of Scientific Affairs at Merck Canada Inc. (CNW Group/Merck Canada Inc.)". Image available at: http://photos.newswire.ca/images/download/20160331_C7532_PHOTO_EN_655043.jpg